Table 5.

Cumulative incidence of anemia in patients with increasing numbers of chemotherapy cycles

		Cycle
Lymphoma/myeloma groups		1	2	3	4	5	6	Total
Non-Hodgkin's lymphoma	Count	12	23	35	38	41	43	69
%	17.4	33.3	50.7	55.1	59.4	62.3	100.0
Hodgkin's lymphoma	Count	7	12	15	18	19	20	40
%	17.5	30.0	37.5	45.0	47.5	50.0	100.0
Multiple myeloma	Count	2	3	3	3	3	3	4
%	50.0	75.0	75.0	75.0	75.0	75.0	100.0
Total	Count	21	38	53	59	63	66	113
%	18.6	33.6	46.9	52.2	55.8	58.4	100.0